Terms: = Prostate cancer AND MUC16, CA125, CA-125 AND Prognosis
26 results:
1. Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.
Wan L; Fan Y; Wu T; Liu Y; Zhang R; Chen S; Zhao C; Xue Y
Eur J Med Res; 2024 Apr; 29(1):242. PubMed ID: 38643190
[TBL] [Abstract] [Full Text] [Related]
2. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
3. FLG Gene Mutation Up-regulates the Abnormal Tumor Immune Response and Promotes the Progression of prostate cancer.
Zhang P; An Z; Sun C; Xu Y; Zhang Z
Curr Pharm Biotechnol; 2022; 23(14):1658-1670. PubMed ID: 35422210
[TBL] [Abstract] [Full Text] [Related]
4. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
Zhang L; Chen H; Ding B; Jiang W
J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
[TBL] [Abstract] [Full Text] [Related]
5. The Combination of ca125 and NSE Is Useful for Predicting Liver Metastasis of Lung cancer.
Wang CF; Peng SJ; Liu RQ; Yu YJ; Ge QM; Liang RB; Li QY; Li B; Shao Y
Dis Markers; 2020; 2020():8850873. PubMed ID: 33376560
[TBL] [Abstract] [Full Text] [Related]
6. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
[TBL] [Abstract] [Full Text] [Related]
7. A case of primary adenocarcinoma of the seminal vesicle treated by total laparoscopic pelvic exenteration.
Tochigi K; Matsukawa Y; Ishida S; Funahashi Y; Fujita T; Kato M; Gotoh M
Aktuelle Urol; 2021 Feb; 52(1):50-53. PubMed ID: 32854127
[TBL] [Abstract] [Full Text] [Related]
8. Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer.
Yu M; Yang C; Wang S; Zeng Y; Chen Z; Feng N; Ning C; Wang L; Xue L; Zhang Z
Clin Chim Acta; 2020 Nov; 510():437-441. PubMed ID: 32791134
[TBL] [Abstract] [Full Text] [Related]
9. Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis.
Jiang H; Guo S; Zhao Y; Wang Y; Piao HY; Wu Y; Zhang J
Pathol Res Pract; 2019 Oct; 215(10):152569. PubMed ID: 31421977
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular metastasis in patients with metastatic lung cancer.
Lin Q; Chen XY; Liu WF; Zhu PW; Shi WQ; Li B; Yuan Q; Min YL; Liu JM; Shao Y
Cancer Med; 2020 Feb; 9(4):1279-1286. PubMed ID: 31218849
[TBL] [Abstract] [Full Text] [Related]
11. A 5-year follow-up of primary seminal vesicle adenocarcinoma: A case report.
Yin T; Jiang Y
Medicine (Baltimore); 2018 Oct; 97(41):e12600. PubMed ID: 30313047
[TBL] [Abstract] [Full Text] [Related]
12. Primary adenocarcinoma of the seminal vesicles. A review of the literature.
Katafigiotis I; Sfoungaristos S; Duvdevani M; Mitsos P; Roumelioti E; Stravodimos K; Anastasiou I; Constantinides CA
Arch Ital Urol Androl; 2016 Mar; 88(1):47-51. PubMed ID: 27072175
[TBL] [Abstract] [Full Text] [Related]
13. Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort.
Bevilacqua V; Chan MK; Chen Y; Armbruster D; Schodin B; Adeli K
Clin Chem; 2014 Dec; 60(12):1532-42. PubMed ID: 25261558
[TBL] [Abstract] [Full Text] [Related]
14. Tumor markers in clinical practice: a review focusing on common solid cancers.
Duffy MJ
Med Princ Pract; 2013; 22(1):4-11. PubMed ID: 22584792
[TBL] [Abstract] [Full Text] [Related]
15. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer.
Poveda A; Kaye SB; McCormack R; Wang S; Parekh T; Ricci D; Lebedinsky CA; Tercero JC; Zintl P; Monk BJ
Gynecol Oncol; 2011 Sep; 122(3):567-72. PubMed ID: 21664658
[TBL] [Abstract] [Full Text] [Related]
16. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
[TBL] [Abstract] [Full Text] [Related]
17. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract] [Full Text] [Related]
18. Epithelioid angiosarcoma: a neoplasm with potential diagnostic challenges.
Lin CF; DeFrias D; Lin X
Diagn Cytopathol; 2010 Feb; 38(2):154-8. PubMed ID: 19813270
[TBL] [Abstract] [Full Text] [Related]
19. Serum proteomics using mass spectrometry.
Hood BL; Malehorn DE; Conrads TP; Bigbee WL
Methods Mol Biol; 2009; 520():107-28. PubMed ID: 19381950
[TBL] [Abstract] [Full Text] [Related]
20. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
Köbel M; Kalloger SE; Boyd N; McKinney S; Mehl E; Palmer C; Leung S; Bowen NJ; Ionescu DN; Rajput A; Prentice LM; Miller D; Santos J; Swenerton K; Gilks CB; Huntsman D
PLoS Med; 2008 Dec; 5(12):e232. PubMed ID: 19053170
[TBL] [Abstract] [Full Text] [Related]
[Next]
